CRISP-HR Therapeutics: Funding, Investors & Team (Sep 2026)
CRISP-HR, we have developed the next great leap in gene-editing technology and CRISPR therapeutics – The Cas9-HR Platform.
CRISP-HR Therapeutics has raised $100k across 1 funding round on record, the most recent a Non-equity Assistance of $100k announced in Mar 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CRISP-HR Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2022.
CRISP-HR Therapeutics Funding Rounds
CRISP-HR Therapeutics Founders and Leadership Team
Contact details for the CRISP-HR Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →CRISP-HR Therapeutics Funding Compared to Other Biotechnology Startups
CRISP-HR Therapeutics' latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CRISP-HR Therapeutics in Biotechnology and San Carlos
Companies Similar to CRISP-HR Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
CRISP-HR Therapeutics Funding FAQs
What does CRISP-HR Therapeutics do?
CRISP-HR, we have developed the next great leap in gene-editing technology and CRISPR therapeutics – The Cas9-HR Platform.
How much funding has CRISP-HR Therapeutics raised?
CRISP-HR Therapeutics has raised $100k across 1 round on record. The most recent is a Non-equity Assistance of $100k announced in Mar 2022.
When did CRISP-HR Therapeutics last raise funding?
CRISP-HR Therapeutics' most recent funding round on record is a Non-equity Assistance of $100k, announced in Mar 2022.
Who is the CEO of CRISP-HR Therapeutics?
Chris Hackley is listed as CEO at CRISP-HR Therapeutics.
Where is CRISP-HR Therapeutics headquartered?
CRISP-HR Therapeutics is based in San Carlos, California, United States.
How many employees does CRISP-HR Therapeutics have?
CRISP-HR Therapeutics is in the 1-10 employee band.
How does CRISP-HR Therapeutics' funding compare to other Biotechnology startups?
CRISP-HR Therapeutics' latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's CRISP-HR Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CRISP-HR Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.